News & Media

Serious players in the biomaterials and bioenergy fields from around the world have converged on Winnipeg for the three-day BIOFIBE2011 Conference.

Medicure Inc. is pleased to announce that the TSX Venture Exchange has granted approval for Medicure to graduate from the NEX, to the TSX Venture Exchange as a Tier 2 issuer.

Ottawa needs to overhaul its flagship R & D program because it spends too much money and fails to show any increase in innovation among Canadian companies, says a federally appointed panel of experts.

As part of Small Business Week, the province is unveiling two new programs, AccessManitoba and Business Programs and Services (BizPaS) to help support small businesses and entrepreneurs set up shop, access services and provide better customer service, Ent

The LSAM Awards Gala was held on October 5, 2011 at the Hotel Fort Garry. Click on the link for a full list of this year’s winners.

The Emerging Life Science Company of the Year award celebrates a company based in Manitoba that is recognized for their growth potential.

Miraculins announced that it has completed an Exclusive Manufacturing and Supply Agreement with Thermo Fisher Scientific Inc.

IMRIS announced that the first published results on the early clinical experiences at hospitals using the IMRIS system, highlight a number of positive findings for procedures and patient outcomes resulting from utilization of the intraoperative MRI capabi

Ag-West Bio leads study to evaluate feasibility of developing crops and processing for bio-jet fuels

Information on the Demonstration and Research and Development funding program Presented by Marc D’Iorio

Theo Wigle, a grade 12 student at Winnipeg’s Shaftesbury High School, was the winner of the 2011 Biotechnology Brain Game

The board of Cold-FX flu remedy maker Afexa Life Sciences Inc. has given its final stamp of approval to a friendly $76-million takeover bid by Valeant Pharmaceuticals International Inc.

Close to 20 positions have been eliminated from the National Research Council's operations in Winnipeg.

Kane Biotech Inc. is pleased to announce the invention and patenting of a new bone tissue regenerating fusion peptide based on the Company’s competence stimulating peptide oral care technology.

IMRIS announced the sale of two systems to a single confidential U.S. customer.

New opportunities for flax producers are firing up with the help of a Government of Canada investment. Flax Power has received more than $87,000 to help increase its production capacity, including the purchase and installation of new production equipment

Cangene Corporation announced that its board of directors has unanimously appointed John A. Sedor as president and chief executive officer.

Conviron president and CEO Steven Kroft told the exchange students while there are challenges associated with global trading, the payoffs can be huge.

IMRIS Inc.announced that it has received a Health Canada medical device license for AccuTrack™ the Company’s 3D image guidance tool for use in IMRIS neurosurgery suites.

A new study, in partnership between The Richardson Centre for Functional Foods and Nutraceuticals and St. Luke's-Roosevelt Hospital, has found a link between weight gain and sleep deprivation.

The first Canadian installation is being tested in Barrie, Ont. The second and third Canadian sales may happen before the end of the year.